Here, we present data from a series of three adult patients with r/r B-ALL, who failed treatment with InO associated with reduced CD22 antigen expression or who developed CD22-negative relapse as revealed by flow cytometry. This evidence concerns the gene CD22 and acute lymphoblastic leukemia.